1 - 6 out of 6Page size: 10
  1. 2023

  2. Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

    Radić, L., Sliepen, K., Yin, V., Brinkkemper, M., Capella-Pujol, J., Schriek, A. I., Torres, J. L., Bangaru, S., Burger, J. A., Poniman, M., Bontjer, I., Bouhuijs, J. H., Gideonse, D., Eggink, D., Ward, A. B., Heck, A. J. R., van Gils, M. J., Sanders, R. W. & Schinkel, J., 21 Apr 2023, In: iScience. 26, 4, 106540.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases

    T2B Consortium, Jun 2023, In: Journal of allergy and clinical immunology. 151, 6, p. 1646-1654 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. 2022

  5. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

    Brouwer, P. J. M., Antanasijevic, A., Ronk, A. J., Müller-Kräuter, H., Watanabe, Y., Claireaux, M., Perrett, H. R., Bijl, T. P. L., Grobben, M., Umotoy, J. C., Schriek, A. I., Burger, J. A., Tejjani, K., Lloyd, N. M., Steijaert, T. H., van Haaren, M. M., Sliepen, K., de Taeye, S. W., van Gils, M. J., Crispin, M., & 4 othersStrecker, T., Bukreyev, A., Ward, A. B. & Sanders, R. W., 14 Dec 2022, In: Cell host & microbe. 30, 12, p. 1759-1772.e12

    Research output: Contribution to journal › Article › Academic › peer-review

  6. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

    Claireaux, M., Caniels, T. G., de Gast, M., Han, J., Guerra, D., Kerster, G., van Schaik, B. D. C., Jongejan, A., Schriek, A. I., Grobben, M., Brouwer, P. J. M., van der Straten, K., Aldon, Y., Capella-Pujol, J., Snitselaar, J. L., Olijhoek, W., Aartse, A., Brinkkemper, M., Bontjer, I., Burger, J. A., & 13 othersPoniman, M., Bijl, T. P. L., Torres, J. L., Copps, J., Martin, I. C., de Taeye, S. W., de Bree, G. J., Ward, A. B., Sliepen, K., van Kampen, A. H. C., Moerland, P. D., Sanders, R. W. & van Gils, M. J., 1 Dec 2022, In: Nature communications. 13, 1, 4539.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 22 Nov 2022, In: Frontiers in immunology. 13, 1091668.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  8. Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 16 May 2022, In: Frontiers in immunology. 13, 893648.

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 10935085